Robert James Wills Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

Robert James Wills is of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Robert James Wills Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 22 2024	SELL Sale (or disposition) back to the issuer	-	30,000 Reduced 100.0%	0 Common Stock

Also insider at

MIST

Milestone Pharmaceuticals Inc. Healthcare

Director

ONCT

Oncternal Therapeutics, Inc. Healthcare

RJW